Target intelligence / Profile preview

RNA exonuclease 2 (REXO2)

Target
REXO2
Molecular classification
Enzyme, Exoribonuclease, DEDDh-family nuclease, RNA-degrading enzyme
01

Overview

RNA exonuclease 2 (REXO2) is an evolutionarily conserved exoribonuclease enzyme, primarily localized in mitochondria, that catalyzes the 3′-to-5′ degradation of short RNA oligonucleotides (nanoRNAs) to mononucleotides. REXO2 belongs to the DEDDh-family of nucleases and forms a homodimer, utilizing a two-magnesium-ion-dependent hydrolysis mechanism. It serves a key role in mitochondrial RNA metabolism by "scavenging" short RNAs produced from processing and decay—helping prevent double-stranded RNA accumulation and maintaining mitochondrial transcriptome integrity. Additionally, REXO2 has activity toward short DNA oligonucleotides and may participate in DNA metabolism. No known drugs directly target REXO2; its major biological importance is in RNA turnover, salvage, and mitochondrial function. Knockdown or depletion of REXO2 leads to RNA and DNA metabolic defects, highlighting its essential cellular function.

Other names
Oligoribonuclease, mitochondrialREXO2SFNSMFNCGI-114DKFZP566E144RNA exonuclease 2 homologSmall fragment nucleaseREX2RFNRNase D homologOrn homolog
02

Biological functions

RNA processingRNA decayDegradation of small (nano)RNAsRNA salvage pathwaysMaintenance of mitochondrial RNA homeostasisPrevention of accumulation of double-stranded RNADNA metabolism (degradation of short DNAs during repair/replication)
03

Disease associations

Other
04

Safety considerations

Depletion or inhibition could disrupt mitochondrial RNA turnover and homeostasisMay cause accumulation of non-coding RNAs and double-stranded RNAs, potentially impacting mitochondrial functionKnockdown may alter resistance to DNA damage (e.g. UV-C)

Beyond the preview

Go deeper on RNA exonuclease 2 (REXO2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA exonuclease 2 (REXO2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call